Contact
Please use this form to send email to PR contact of this press release:
Ambrx to Present Preliminary ARX517 First-in-Human Safety, Efficacy, and Pharmacokinetics Data at ESMO 2023
TO:
Please use this form to send email to PR contact of this press release:
Ambrx to Present Preliminary ARX517 First-in-Human Safety, Efficacy, and Pharmacokinetics Data at ESMO 2023
TO: